NCT02966925View on ClinicalTrials.gov

Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Vulvar Atrophy
Interventions
DEVICE

Cellular Matrix BCT-HA Kit

Submucosal injections in the vulva, in the posterior vaginal wall and in the perineum of a combination product made of PRP and HA prepared using the Cellular Matrix BCT-HA medical device

Trial Locations (1)

94010

Centre Hospitalier Universitaire Henri Mondor, Créteil

All Listed Sponsors
lead

Regen Lab SA

INDUSTRY

NCT02966925 - Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness | Biotech Hunter | Biotech Hunter